![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/245 | |
A61K 31/353 | |||
A61K 31/502 | |||
A61K 31/706 | |||
A61K 31/7068 | |||
A61K 45/06 | |||
A61P 35/00 |
(11) | Number of the document | 2307002 |
(13) | Kind of document | T |
(96) | European patent application number | 09761954.8 |
Date of filing the European patent application | 2009-06-05 | |
(97) | Date of publication of the European application | 2011-04-13 |
(45) | Date of publication and mention of the grant of the patent | 2013-01-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2009/001418 |
Date | 2009-06-05 |
(87) | Number | WO 2009/150405 |
Date | 2009-12-17 |
(30) | Number | Date | Country code |
0810552 | 2008-06-09 | GB | |
0906696 | 2009-04-17 | GB |
(72) |
GREEN, Simon, Richard, GB
MACKAY, Ruth, GB
FLEMING, Ian, Neil, GB
|
(73) |
Cyclacel Limited,
411 Tower Bridge Business Centre 46-48 East Smithfield, London E1W 1AW,
GB
|
(54) | COMBINATIONS OF SAPACITABINE OR CNDAC WITH DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE |
COMBINATIONS OF SAPACITABINE OR CNDAC WITH DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE |